N. Ghilezan

发表

Radiotherapy versus Concurrent 5-Day Cisplatin and Radiotherapy in Locally Advanced Cervical Carcinoma

V. Nagy, N. Todor, C. Ordeanu, 2009, Strahlentherapie und Onkologie.

Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial.

M. Inbar, C. Wiltschke, T. Brodowicz, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship of Circulating Tumor Cells ’ Detection to Serologic and Imaging Response in Germ Cell Tumors : a pilot study . Is it a new prognostic factor in a new Era ?

Rare, N. Ghilezan, C. Cebotaru, 2011 .

Doubling epirubicin dose intensity ( 100 mg / m 2 versus 50 mg / m 2 ) in the FEC regimen significantly increases response rates . An international randomised phase III study in metastatic breast cancer

G. Brufman, A. Martoni, E. Colajori, 2004 .

Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer. The Epirubicin High Dose (HEPI 010) Study Group.

G. Brufman, C. Zielinski, E. Colajori, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma (NPC)

T. Ciuleanu, E. Ciuleanu, N. Todor, 1999 .

Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study.

T. Ciuleanu, E. Ciuleanu, N. Todor, 2008, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.

T. Ciuleanu, D. Cernea, N. Todor, 2007, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.

Tudor Ciuleanu, Jacek Jassem, R. Ramlau, 2006, Lung cancer.

Quality of life and treatment related toxicity in 335 patients with locally advanced cervical carcinoma treated by two chemoradiation regimens.

V. Nagy, N. Todor, C. Ordeanu, 2007, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial.

George Fountzilas, Nikolaos Zamboglou, A. Dimitriadis, 2004, International journal of radiation oncology, biology, physics.

Paclitaxel and carboplatin in relapsed or metastatic nasopharyngeal carcinoma: a multicenter phase II study.

T. Ciuleanu, G. Fountzilas, E. Ciuleanu, 2004, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

A phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

L. Neamtiu, D. Grecea, N. Ghilezan, 2005 .

Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma.

V. Nagy, N. Todor, C. Ordeanu, 2007, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Gemcitabine and cisplatin (GC) +/- subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)

R. Ramlau, M. Krzakowski, T. Brodowicz, 2004 .

A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis

V. Ostapenko, N. Badri, E. Mickiewicz, 2001 .